Table 1.

Kinetic properties of homomeric GluA1 and GluA2(Q) receptors and heteromeric GluA1/A2(R) receptors coexpressed with CNIH-1, CNIH-2, CNIH-3, or γ-2

Deactivation (τw, deact, ms)Desensitization (τw, des, ms)Steady-state current (% peak)
GluA11.3 ± 0.2 (10)2.6 ± 0.1 (22)1.9 ± 0.3 (22)
    +CNIH-11.0 ± 0.2 (6)#2.3 ± 0.1 (6)1.9 ± 1.1 (6)
    +CNIH-24.0 ± 0.8 (10)*5.5 ± 0.6 (15)***,#6.7 ± 2.3 (15)
    +CNIH-33.3 ± 0.6 (14)*5.0 ± 0.6 (10)***4.1 ± 1.4 (10)
    +γ-22.1 ± 0.2 (11)*3.9 ± 0.2 (20)***3.6 ± 0.5 (20)*
GluA1/A2(R)0.8 ± 0.1 (5)5.5 ± 0.3 (13)3.8 ± 0.7 (13)
    +CNIH-214.1 ± 3.7 (6)*15.2 ± 5.2 (6)**
    +CNIH-31.3 ± 0.1 (10)**10.9 ± 1.9 (10)***13.2 ± 3.2 (10)**
    +γ-27.7 ± 0.5 (12)*20.4 ± 2.4 (12)***
GluA2(Q)1.0 ± 0.2 (11)5.0 ± 0.2 (25)1.8 ± 0.2 (25)
    +CNIH-212.1 ± 1.4 (9)***8.9 ± 2.4 (9)*
    +CNIH-312.3 ± 4.5 (6)**25.5 ± 3.7 (12)***,###11.3 ± 2.4 (12)***
    +γ-210.2 ± 1.0 (12)***6.7 ± 1.5 (12)**
  • Values are mean ± SEM (n). Tests of differences among group data were performed using a Kruskal–Wallis rank-sum test followed by pairwise Wilcoxon rank-sum tests with Holm's sequential Bonferroni correction. Statistical significance of single comparisons [GluA2(Q) and GluA1/A2 deactivation] was determined using a Wilcoxon rank-sum test.

  • *p < 0.05,

  • **p < 0.01,

  • ***p < 0.001 compared with AMPAR alone.

  • #p < 0.05,

  • ###p < 0.001 compared with +γ-2 condition.